Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1993 Nov 15;90(22):10764–10768. doi: 10.1073/pnas.90.22.10764

Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer.

G Bandara 1, G M Mueller 1, J Galea-Lauri 1, M H Tindal 1, H I Georgescu 1, M K Suchanek 1, G L Hung 1, J C Glorioso 1, P D Robbins 1, C H Evans 1
PMCID: PMC47858  PMID: 8248169

Abstract

Gene therapy offers a radical different approach to the treatment of arthritis. Here we have demonstrated that two marker genes (lacZ and neo) and cDNA coding for a potentially therapeutic protein (human interleukin 1-receptor-antagonist protein; IRAP or IL-1ra) can be delivered, by ex vivo techniques, to the synovial lining of joints; intraarticular expression of IRAP inhibited intraarticular responses to interleukin 1. To achieve this, lapine synoviocytes were first transduced in culture by retroviral infection. The genetically modified synovial cells were then transplanted by intraarticular injection into the knee joints of rabbits, where they efficiently colonized the synovium. Assay of joint lavages confirmed the in vivo expression of biologically active human IRAP. With allografted cells, IRAP expression was lost by 12 days after transfer. In contrast, autografted synoviocytes continued to express IRAP for approximately 5 weeks. Knee joints expressing human IRAP were protected from the leukocytosis that otherwise follows the intraarticular injection of recombinant human interleukin 1 beta. Thus, we report the intraarticular expression and activity of a potentially therapeutic protein by gene-transfer technology; these experiments demonstrate the feasibility of treating arthritis and other joint disorders with gene therapy.

Full text

PDF
10764

Images in this article

10765Fig. 1
on p.10765
10766Fig. 2
on p.10766

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arner E. C., Di Meo T. M., Ruhl D. M., Pratta M. A. In vivo studies on the effects of human recombinant interleukin-1 beta on articular cartilage. Agents Actions. 1989 Jun;27(3-4):254–257. doi: 10.1007/BF01972789. [DOI] [PubMed] [Google Scholar]
  2. Bandara G., Lin C. W., Georgescu H. I., Evans C. H. The synovial activation of chondrocytes: evidence for complex cytokine interactions involving a possible novel factor. Biochim Biophys Acta. 1992 Apr 7;1134(3):309–318. doi: 10.1016/0167-4889(92)90192-e. [DOI] [PubMed] [Google Scholar]
  3. Bandara G., Robbins P. D., Georgescu H. I., Mueller G. M., Glorioso J. C., Evans C. H. Gene transfer to synoviocytes: prospects for gene treatment of arthritis. DNA Cell Biol. 1992 Apr;11(3):227–231. doi: 10.1089/dna.1992.11.227. [DOI] [PubMed] [Google Scholar]
  4. Carter D. B., Deibel M. R., Jr, Dunn C. J., Tomich C. S., Laborde A. L., Slightom J. L., Berger A. E., Bienkowski M. J., Sun F. F., McEwan R. N. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature. 1990 Apr 12;344(6267):633–638. doi: 10.1038/344633a0. [DOI] [PubMed] [Google Scholar]
  5. Dinarello C. A., Thompson R. C. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today. 1991 Nov;12(11):404–410. doi: 10.1016/0167-5699(91)90142-G. [DOI] [PubMed] [Google Scholar]
  6. Dranoff G., Jaffee E., Lazenby A., Golumbek P., Levitsky H., Brose K., Jackson V., Hamada H., Pardoll D., Mulligan R. C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3539–3543. doi: 10.1073/pnas.90.8.3539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dripps D. J., Brandhuber B. J., Thompson R. C., Eisenberg S. P. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem. 1991 Jun 5;266(16):10331–10336. [PubMed] [Google Scholar]
  8. Evans C. H., Bandara G., Mueller G., Robbins P., Glorioso J. C., Georgescu H. I. Synovial cell transplants for gene transfer to joints. Transplant Proc. 1992 Dec;24(6):2966–2966. [PubMed] [Google Scholar]
  9. Georgescu H. I., Mendelow D., Evans C. H. HIG-82: an established cell line from rabbit periarticular soft tissue, which retains the "activatable" phenotype. In Vitro Cell Dev Biol. 1988 Oct;24(10):1015–1022. doi: 10.1007/BF02620875. [DOI] [PubMed] [Google Scholar]
  10. Hannum C. H., Wilcox C. J., Arend W. P., Joslin F. G., Dripps D. J., Heimdal P. L., Armes L. G., Sommer A., Eisenberg S. P., Thompson R. C. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 1990 Jan 25;343(6256):336–340. doi: 10.1038/343336a0. [DOI] [PubMed] [Google Scholar]
  11. Henderson B., Thompson R. C., Hardingham T., Lewthwaite J. Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist. Cytokine. 1991 May;3(3):246–249. doi: 10.1016/1043-4666(91)90023-7. [DOI] [PubMed] [Google Scholar]
  12. Linn J. E., Hardin J. G., Halla J. T. A controlled study of ANA+ RF- arthritis. Arthritis Rheum. 1978 Jul-Aug;21(6):645–651. doi: 10.1002/art.1780210606. [DOI] [PubMed] [Google Scholar]
  13. McDonnell J., Hoerrner L. A., Lark M. W., Harper C., Dey T., Lobner J., Eiermann G., Kazazis D., Singer I. I., Moore V. L. Recombinant human interleukin-1 beta-induced increase in levels of proteoglycans, stromelysin, and leukocytes in rabbit synovial fluid. Arthritis Rheum. 1992 Jul;35(7):799–805. doi: 10.1002/art.1780350714. [DOI] [PubMed] [Google Scholar]
  14. Ohashi T., Boggs S., Robbins P., Bahnson A., Patrene K., Wei F. S., Wei J. F., Li J., Lucht L., Fei Y. Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11332–11336. doi: 10.1073/pnas.89.23.11332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Palmer T. D., Rosman G. J., Osborne W. R., Miller A. D. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1330–1334. doi: 10.1073/pnas.88.4.1330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pettipher E. R., Higgs G. A., Henderson B. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci U S A. 1986 Nov;83(22):8749–8753. doi: 10.1073/pnas.83.22.8749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Price J., Turner D., Cepko C. Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc Natl Acad Sci U S A. 1987 Jan;84(1):156–160. doi: 10.1073/pnas.84.1.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sanes J. R., Rubenstein J. L., Nicolas J. F. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 1986 Dec 1;5(12):3133–3142. doi: 10.1002/j.1460-2075.1986.tb04620.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Schwab J. H., Anderle S. K., Brown R. R., Dalldorf F. G., Thompson R. C. Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect Immun. 1991 Dec;59(12):4436–4442. doi: 10.1128/iai.59.12.4436-4442.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. St Louis D., Verma I. M. An alternative approach to somatic cell gene therapy. Proc Natl Acad Sci U S A. 1988 May;85(9):3150–3154. doi: 10.1073/pnas.85.9.3150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sung K., Mendelow D., Georgescu H. I., Evans C. H. Characterisation of chondrocyte activation in response to cytokines synthesised by a synovial cell line. Biochim Biophys Acta. 1988 Sep 16;971(2):148–156. doi: 10.1016/0167-4889(88)90186-3. [DOI] [PubMed] [Google Scholar]
  22. Werb Z., Burleigh M. C. A specific collagenase from rabbit fibroblasts in monolayer culture. Biochem J. 1974 Feb;137(2):373–385. doi: 10.1042/bj1370373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Westacott C. I., Whicher J. T., Barnes I. C., Thompson D., Swan A. J., Dieppe P. A. Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis. 1990 Sep;49(9):676–681. doi: 10.1136/ard.49.9.676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Yelin E. Arthritis. The cumulative impact of a common chronic condition. Arthritis Rheum. 1992 May;35(5):489–497. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES